Format
Sort by
Items per page

Send to

Choose Destination

Best matches for oral contraceptives depression:

Association of Hormonal Contraception With Depression. Skovlund CW et al. JAMA Psychiatry. (2016)

Premenstrual Dysphoric Disorder. Lanza di Scalea T et al. Psychiatr Clin North Am. (2017)

Hormonal Contraception and Its Association With Depression. Grant EC et al. JAMA Psychiatry. (2017)

Search results

Items: 1 to 20 of 1228

1.

No pills, more skills: The adverse effect of hormonal contraceptive use on exposure therapy benefit.

Raeder F, Heidemann F, Schedlowski M, Margraf J, Zlomuzica A.

J Psychiatr Res. 2019 Dec;119:95-101. doi: 10.1016/j.jpsychires.2019.09.016. Epub 2019 Sep 28.

PMID:
31590077
2.

Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women.

de Wit AE, Booij SH, Giltay EJ, Joffe H, Schoevers RA, Oldehinkel AJ.

JAMA Psychiatry. 2019 Oct 2. doi: 10.1001/jamapsychiatry.2019.2838. [Epub ahead of print]

PMID:
31577333
3.

Oral contraceptive use in adolescence predicts lasting vulnerability to depression in adulthood.

Anderl C, Li G, Chen FS.

J Child Psychol Psychiatry. 2019 Aug 28. doi: 10.1111/jcpp.13115. [Epub ahead of print]

PMID:
31461541
4.

Premenstrual Dysphoric Disorder.

Lanza di Scalea T, Pearlstein T.

Med Clin North Am. 2019 Jul;103(4):613-628. doi: 10.1016/j.mcna.2019.02.007. Review.

PMID:
31078196
5.

Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions.

Gumbie M, Parkinson B, Cutler H, Gauld N, Mumford V.

Pharmacoeconomics. 2019 Aug;37(8):1049-1064. doi: 10.1007/s40273-019-00804-6.

PMID:
31069781
6.

Oral contraceptive use and depression among adolescents.

McKetta S, Keyes KM.

Ann Epidemiol. 2019 Jan;29:46-51. doi: 10.1016/j.annepidem.2018.10.002. Epub 2018 Oct 13.

PMID:
30674431
7.

Case Report: Persistent Genital Arousal Disorder in an Adolescent Woman.

Curran KA.

J Pediatr Adolesc Gynecol. 2019 Apr;32(2):186-188. doi: 10.1016/j.jpag.2018.11.009. Epub 2018 Dec 1.

PMID:
30513343
8.

Negative cognitive styles as risk factors for the occurrence of PMS and PMDD.

ƚliwerski A, Bielawska-Batorowicz E.

J Reprod Infant Psychol. 2019 Jul;37(3):322-337. doi: 10.1080/02646838.2018.1543943. Epub 2018 Nov 23.

PMID:
30468400
9.

Increased frequency of mind wandering in healthy women using oral contraceptives.

Raymond C, Marin MF, Juster RP, Leclaire S, Bourdon O, Cayer-Falardeau S, Lupien SJ.

Psychoneuroendocrinology. 2019 Mar;101:121-127. doi: 10.1016/j.psyneuen.2018.11.005. Epub 2018 Nov 8.

PMID:
30453124
10.

Treatment of Depression in Women.

Bourne C, Kenkel L.

Handb Exp Pharmacol. 2019;250:371-387. doi: 10.1007/164_2018_163.

PMID:
30341726
11.

Hormonal Contraception, depression, and Academic Performance among females attending college in the United States.

Gregory ST, Hall K, Quast T, Gatto A, Bleck J, Storch EA, DeBate R.

Psychiatry Res. 2018 Dec;270:111-116. doi: 10.1016/j.psychres.2018.09.029. Epub 2018 Sep 15.

PMID:
30245373
12.
13.

Do Progestin-Only Contraceptives Contribute to the Risk of Developing Depression as Implied by Beta-Arrestin 1 Levels in Leukocytes? A Pilot Study.

Smith K, Nayyar S, Rana T, Archibong AE, Looney KR, Nayyar T.

Int J Environ Res Public Health. 2018 Sep 9;15(9). pii: E1966. doi: 10.3390/ijerph15091966.

14.

Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: A retrospective study of 954,186 patients.

Jacob L, John M, Kalder M, Kostev K.

Curr Med Mycol. 2018 Mar;4(1):6-11. doi: 10.18502/cmm.4.1.27.

15.

Resetting the Stress System with a Mifepristone Challenge.

Dalm S, Karssen AM, Meijer OC, Belanoff JK, de Kloet ER.

Cell Mol Neurobiol. 2019 May;39(4):503-522. doi: 10.1007/s10571-018-0614-5. Epub 2018 Sep 1.

16.

Glucocorticoid receptor activation induces decrease of hippocampal astrocyte number in rats.

Lou YX, Li J, Wang ZZ, Xia CY, Chen NH.

Psychopharmacology (Berl). 2018 Sep;235(9):2529-2540. doi: 10.1007/s00213-018-4936-2. Epub 2018 Aug 1.

PMID:
30069586
17.

Correlations between changes in the hypothalamic-pituitary-adrenal axis and neurochemistry of the anterior cingulate gyrus in postpartum depression.

de Rezende MG, Rosa CE, Garcia-Leal C, de Figueiredo FP, Cavalli RC, Bettiol H, Salmon CEG, Barbieri MA, de Castro M, Carlos Dos Santos A, Del-Ben CM.

J Affect Disord. 2018 Oct 15;239:274-281. doi: 10.1016/j.jad.2018.07.028. Epub 2018 Jul 10.

PMID:
30029155
18.

Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders.

Roat-Shumway S, Wroolie TE, Watson K, Schatzberg AF, Rasgon NL.

J Affect Disord. 2018 Oct 15;239:242-246. doi: 10.1016/j.jad.2018.07.014. Epub 2018 Jul 10.

PMID:
30025313
19.

Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action.

Golier JA, Yehuda R.

Biol Psychiatry. 2018 Jul 1;84(1):5-6. doi: 10.1016/j.biopsych.2018.05.004. No abstract available.

PMID:
29929578
20.

Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice.

Slattery J, Morales D, Pinheiro L, Kurz X.

Drug Saf. 2018 Oct;41(10):951-958. doi: 10.1007/s40264-018-0683-x.

PMID:
29785475

Supplemental Content

Loading ...
Support Center